Month: October 2022

Oct 19 2022

Uncategorized

‘I just want my life back’: Why are people with schizophrenia waiting for medication that works?

by Clinical Editor

No Comments

She also has schizoaffective disorder, which combines the symptoms of both schizophrenia and a mood disorder — in her case, bipolar disorder. At her sickest, in the early 2010s, she...

Oct 19 2022

Uncategorized

These rats have human cells in their brains. They may help scientists understand autism and schizophrenia.

by Clinical Editor

No Comments

Stanford researcher Sergiu Pașca’s experiments, published Wednesday in the journal Nature, are both significant and ethically challenging.

Oct 19 2022

Uncategorized

Could a Refuted 120-Year-Old Theory Actually Be True? Similarity Between Dementia and Schizophrenia Discovered

by Clinical Editor

No Comments

For the first time, researchers compared schizophrenia and frontotemporal dementia, two conditions that affect the frontal and temporal lobes of the brain. Rarely do researchers in basic science …

Oct 19 2022

Uncategorized

A Texas officer who shot and killed a woman with schizophrenia in 2019 is found not guilty of aggravated assault

by Clinical Editor

No Comments

An officer in Baytown, Texas, who fatally shot a woman with schizophrenia in 2019 was found not guilty of aggravated assault by a public servant on Tuesday, a court document...

Oct 19 2022

Uncategorized

Five Schizophrenia Coping Skills I Can’t Live Without

by Clinical Editor

No Comments

My hope is that if you struggle with schizophrenia yourself, the following coping mechanisms might give you some relief from your illness as well. One of the best steps I...

Oct 18 2022

Uncategorized

FDA spurns Minerva’s schizophrenia drug in RTF, sending share price into tailspin – Endpoints News

by Clinical Editor

No Comments

FDA spurns Minerva’s schizophrenia drug in RTF, sending share price into tailspin  Endpoints News Minerva Shares Plunge After FDA Rejects Schizophrenia Drug Candidate  BioSpace Minerva Neurosciences Shares Sink On Regulatory Setback For...

Oct 18 2022

Uncategorized

‘I just want my life back’: Why are people with schizophrenia waiting for medication that works?

by Clinical Editor

No Comments

She also has schizoaffective disorder, which combines the symptoms of both schizophrenia and a mood disorder — in her case, bipolar disorder. At her sickest, in the early 2010s, she...

Oct 18 2022

Uncategorized

These rats have human cells in their brains. They may help scientists understand autism and schizophrenia.

by Clinical Editor

No Comments

Stanford researcher Sergiu Pașca’s experiments, published Wednesday in the journal Nature, are both significant and ethically challenging.

Oct 18 2022

Uncategorized

Could a Refuted 120-Year-Old Theory Actually Be True? Similarity Between Dementia and Schizophrenia Discovered

by Clinical Editor

No Comments

For the first time, researchers compared schizophrenia and frontotemporal dementia, two conditions that affect the frontal and temporal lobes of the brain. Rarely do researchers in basic science …

Oct 18 2022

Uncategorized

Minerva Neurosciences Shares Sink On Regulatory Setback For Schizophrenia Candidate

by Clinical Editor

No Comments

Minerva Neurosciences Inc (NASDAQ: NERV) has received a refusal to file letter from the FDA regarding its marketing application for roluperidone for negative symptoms in patients with schizophrenia.